Addus HomeCare (NASDAQ:ADUS) Posts Earnings Results, Misses Expectations By $0.09 EPS

Addus HomeCare (NASDAQ:ADUS) issued its quarterly earnings data on Monday. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09), Zacks reports. The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%.

Addus HomeCare Stock Down 10.4 %

Addus HomeCare stock opened at $97.53 on Wednesday. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.72. The company’s 50-day moving average price is $123.94 and its 200-day moving average price is $126.50. The company has a market cap of $1.77 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Oppenheimer boosted their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Stephens raised their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Buy” and an average target price of $134.22.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.